Using the CareStartTM G6PD test kit, this study identified a prevalence of 4.3% G6PD deficiency among febrile patients in southwestern Ethiopia based on a threshold cutoff of 1.88 U/g Hb (i.e. < 30% of the AMM G6PD activity). Here, G6PD is linked to G6PD deficiency.